Variant report

Variant	esv3365555
Chromosome Location	chr6:150463284-150466132
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:150463766-150464064	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr6:150464335-150464775	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr6:150465618-150465684	K562	blood:	n/a	n/a
4	BHLHE40	chr6:150463969-150464551	K562	blood:	n/a	n/a
5	BHLHE40	chr6:150465179-150465378	K562	blood:	n/a	n/a
6	CBX3	chr6:150463796-150464328	K562	blood:	n/a	n/a
7	CCNT2	chr6:150463711-150465001	K562	blood:	n/a	chr6:150464656-150464665
8	CEBPB	chr6:150463488-150463753	K562	blood:	n/a	n/a
9	CEBPB	chr6:150463497-150463697	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr6:150465663-150465991	K562	blood:	n/a	chr6:150465959-150465972 chr6:150465824-150465837
11	CEBPB	chr6:150463483-150463720	A549	lung:	n/a	n/a
12	CEBPB	chr6:150463462-150463750	IMR90	lung:	n/a	n/a
13	CHD2	chr6:150464718-150464862	K562	blood:	n/a	n/a
14	CTCF	chr6:150464529-150464547	MCF-7	breast:	n/a	n/a
15	CTCF	chr6:150464741-150464843	A549	lung:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
16	CTCF	chr6:150464731-150464858	LNCaP	prostate:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
17	CTCF	chr6:150464700-150464850	WERI-Rb-1	eye:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
18	CTCF	chr6:150464700-150464850	Caco-2	colon:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
19	CTCF	chr6:150464606-150464802	K562	blood:	n/a	n/a
20	CTCF	chr6:150464700-150464850	RPTEC	kidney:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
21	CTCF	chr6:150463900-150464050	SAEC	small airway:	n/a	n/a
22	CTCF	chr6:150464640-150464790	HMEC	breast:	n/a	n/a
23	CTCF	chr6:150464492-150464526	MCF-7	breast:	n/a	n/a
24	CTCF	chr6:150464680-150464830	SAEC	small airway:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
25	CTCF	chr6:150464620-150464770	SAEC	small airway:	n/a	n/a
26	CTCF	chr6:150464720-150464870	HRE	kidney:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
27	CTCF	chr6:150464720-150464870	NHEK	skin:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
28	CTCF	chr6:150464734-150464846	MCF-7	breast:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
29	CTCF	chr6:150464733-150464854	MCF-7	breast:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
30	CTCF	chr6:150464660-150464810	HEK293	kidney:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
31	CTCF	chr6:150464745-150464836	MCF-7	breast:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
32	CTCF	chr6:150464800-150464950	Caco-2	colon:	n/a	n/a
33	CTCF	chr6:150464729-150464846	HepG2	liver:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
34	CTCF	chr6:150464186-150464195	Kidney_OC	kidney:	n/a	n/a
35	CTCF	chr6:150464740-150464890	GM06990	blood:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
36	CTCF	chr6:150464680-150464830	GM12874	blood:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
37	CTCF	chr6:150463940-150464090	HRE	kidney:	n/a	n/a
38	CTCF	chr6:150463720-150463870	HRE	kidney:	n/a	n/a
39	CTCF	chr6:150464731-150464863	ProgFib	skin:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
40	CTCF	chr6:150464660-150464810	AG04449	skin:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
41	CTCF	chr6:150463740-150463890	SAEC	small airway:	n/a	n/a
42	CTCF	chr6:150464784-150464825	H1-hESC	embryonic stem cell:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
43	CTCF	chr6:150465260-150465410	HEK293	kidney:	n/a	n/a
44	CTCF	chr6:150464464-150464563	MCF-7	breast:	n/a	n/a
45	CTCF	chr6:150464743-150464861	Fibrobl	skin:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
46	CTCF	chr6:150464717-150464909	NHEK	skin:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
47	CTCF	chr6:150464700-150464850	HMEC	breast:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
48	CTCF	chr6:150463700-150463850	HMEC	breast:	n/a	n/a
49	CTCF	chr6:150464757-150464809	HepG2	liver:	n/a	chr6:150464788-150464804 chr6:150464787-150464805
50	CTCF	chr6:150464640-150464790	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:150464644-150464694	BJ	skin:	n/a
2	chr6:150463775-150463825	HCF	heart:	n/a
3	chr6:150463417-150463467	PANC-1	pancreas:	n/a
4	chr6:150463500-150463550	HPAEpiC	pulmonary alveolar:	n/a
5	chr6:150463965-150464015	HCT-116	colon:	n/a
6	chr6:150464644-150464694	SK-N-SH	brain:	n/a
7	chr6:150464265-150464315	HCT-116	colon:	n/a
8	chr6:150464644-150464694	PrEC	prostate:	n/a
9	chr6:150463417-150463467	GM12878	blood:	n/a
10	chr6:150464020-150464070	BE2_C	brain:	n/a
11	chr6:150464000-150464050	ovcar-3	ovarian:	n/a
12	chr6:150464644-150464694	NHBE	bronchial:	n/a
13	chr6:150463775-150463825	AG04450	lung:	fetal
14	chr6:150465049-150465099	PANC-1	pancreas:	n/a
15	chr6:150465049-150465099	SK-N-MC	brain:	n/a
16	chr6:150464124-150464174	Hela-S3	cervix:	n/a
17	chr6:150464000-150464050	HEEpiC	esophagus:	n/a
18	chr6:150464990-150465040	NHBE	bronchial:	n/a
19	chr6:150464124-150464174	IMR90	lung:	fetal
20	chr6:150464990-150465040	PANC-1	pancreas:	n/a
21	chr6:150464000-150464050	PANC-1	pancreas:	n/a
22	chr6:150464117-150464167	Hela-S3	cervix:	n/a
23	chr6:150464000-150464050	CMK	blood:	n/a
24	chr6:150464020-150464070	AG04449	skin:	fetal
25	chr6:150463965-150464015	GM19239	blood:	n/a
26	chr6:150464990-150465040	GM12878	blood:	n/a
27	chr6:150463775-150463825	BE2_C	brain:	n/a
28	chr6:150463990-150464040	HNPCEpiC	eye:	n/a
29	chr6:150463775-150463825	AG09319	gingival:	n/a
30	chr6:150464990-150465040	AG09319	gingival:	n/a
31	chr6:150463417-150463467	SAEC	small airway:	n/a
32	chr6:150464000-150464050	ProgFib	skin:	n/a
33	chr6:150464000-150464050	GM12891	blood:	n/a
34	chr6:150464124-150464174	PrEC	prostate:	n/a
35	chr6:150463775-150463825	HEK293	kidney:	embryo
36	chr6:150465049-150465099	HPAEpiC	pulmonary alveolar:	n/a
37	chr6:150464000-150464050	HCF	heart:	n/a
38	chr6:150463965-150464015	HEK293	kidney:	embryo
39	chr6:150464990-150465040	SKMC	muscle:	n/a
40	chr6:150464644-150464694	NB4	blood:	n/a
41	chr6:150464124-150464174	ECC-1	luminal epithelium:	n/a
42	chr6:150463775-150463825	Caco-2	colon:	n/a
43	chr6:150464265-150464315	K562	blood:	n/a
44	chr6:150463965-150464015	MCF10A-Er-Src	breast:	n/a
45	chr6:150463965-150464015	Jurkat	blood:	n/a
46	chr6:150464265-150464315	HUVEC	blood vessel:	n/a
47	chr6:150464990-150465040	AG10803	skin:	n/a
48	chr6:150464644-150464694	GM12878	blood:	n/a
49	chr6:150463990-150464040	Caco-2	colon:	n/a
50	chr6:150463775-150463825	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:150461000..150463300-chr6:150463460..150465278,2	MCF-7	breast:
2	chr6:150401453..150402381-chr6:150464218..150464794,3	MCF-7	breast:
3	chr6:150462370..150464017-chr6:150474588..150477355,2	K562	blood:
4	chr6:150460907..150462974-chr6:150465892..150468393,3	MCF-7	breast:
5	chr17:78233901..78236190-chr6:150464382..150465882,2	MCF-7	breast:
6	chr6:150465090..150467055-chr6:150662955..150664731,2	K562	blood:
7	chr6:150464023..150466191-chr6:150484823..150488710,3	K562	blood:

Variant related genes	Relation type
PPP1R14C	TF binding region
PPP1R14C	CpG island
ENSG00000238594	chromatin interactions
ENSG00000198729	chromatin interactions
ENSG00000173821	chromatin interactions

Extended variants
information (count: 89 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7755565	chr6:150463376-150463377	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs543789564	chr6:150463406-150463407	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs146033658	chr6:150463414-150463415	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs577238020	chr6:150463481-150463482	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs188908698	chr6:150463589-150463590	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs560402090	chr6:150463610-150463611	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs530591500	chr6:150463760-150463761	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs543798517	chr6:150463839-150463840	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs190797361	chr6:150463874-150463875	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs35455053	chr6:150463883-150463884	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs551113254	chr6:150463954-150463955	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs564446817	chr6:150463965-150463966	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs533369117	chr6:150463993-150463994	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs546937176	chr6:150464018-150464019	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs532626070	chr6:150464100-150464101	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs146769348	chr6:150464188-150464189	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs567194678	chr6:150464215-150464216	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs182267012	chr6:150464231-150464232	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs549587273	chr6:150464243-150464244	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs569366139	chr6:150464269-150464270	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs550615489	chr6:150464291-150464292	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs537519161	chr6:150464315-150464316	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs557432817	chr6:150464326-150464327	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs559624927	chr6:150464350-150464351	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs2297672	chr6:150464356-150464357	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs533580192	chr6:150464392-150464393	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs373986485	chr6:150464440-150464441	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs553781481	chr6:150464466-150464467	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs112493035	chr6:150464475-150464476	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs200448500	chr6:150464476-150464477	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs573909762	chr6:150464501-150464502	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs565907459	chr6:150464585-150464586	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs552647889	chr6:150464611-150464612	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs542443897	chr6:150464622-150464623	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs186520059	chr6:150464647-150464648	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs576328108	chr6:150464652-150464653	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs544671530	chr6:150464661-150464662	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs371117131	chr6:150464665-150464666	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs35311704	chr6:150464713-150464714	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs564580572	chr6:150464722-150464723	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs533356607	chr6:150464739-150464740	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs546999510	chr6:150464761-150464762	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs560607402	chr6:150464762-150464763	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs529555432	chr6:150464783-150464784	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs374673522	chr6:150464834-150464835	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs549432591	chr6:150464851-150464852	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs569059490	chr6:150464862-150464863	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538057687	chr6:150464905-150464906	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs76168389	chr6:150464906-150464907	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs528676546	chr6:150464921-150464922	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD

Chromatin state (count:423 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150461200-150463400	Weak transcription	Rectal Mucosa Donor 31	rectum
2	chr6:150462200-150463600	Weak transcription	Right Atrium	heart
3	chr6:150463000-150463400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
4	chr6:150463000-150463400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr6:150463000-150463400	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr6:150463000-150463400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr6:150463000-150463400	Bivalent Enhancer	Fetal Kidney	kidney
8	chr6:150463000-150463400	Bivalent Enhancer	K562	blood
9	chr6:150463000-150463600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr6:150463000-150463600	Bivalent Enhancer	Colonic Mucosa	Colon
11	chr6:150463000-150463600	Bivalent Enhancer	Fetal Thymus	thymus
12	chr6:150463000-150463800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr6:150463000-150463800	Bivalent Enhancer	Duodenum Mucosa	Duodenum
14	chr6:150463000-150465400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr6:150463200-150463400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr6:150463200-150463400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr6:150463200-150463400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr6:150463200-150463400	Flanking Bivalent TSS/Enh	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr6:150463200-150463400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
20	chr6:150463200-150463400	Enhancers	Primary T killer memory cells from peripheral blood	blood
21	chr6:150463200-150463400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr6:150463200-150463400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr6:150463200-150463400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr6:150463200-150463400	Bivalent Enhancer	Brain Angular Gyrus	brain
25	chr6:150463200-150463400	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
26	chr6:150463200-150463400	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
27	chr6:150463200-150463400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr6:150463200-150463400	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
29	chr6:150463200-150463400	Bivalent Enhancer	Fetal Lung	lung
30	chr6:150463200-150463400	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr6:150463200-150463400	Enhancers	Left Ventricle	heart
32	chr6:150463200-150463400	Enhancers	Right Ventricle	heart
33	chr6:150463200-150463400	Flanking Bivalent TSS/Enh	HSMM	muscle
34	chr6:150463200-150463400	Flanking Bivalent TSS/Enh	Osteobl	bone
35	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
37	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
38	chr6:150463200-150463600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr6:150463200-150463600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr6:150463200-150463600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
42	chr6:150463200-150463600	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr6:150463200-150463600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
44	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	Muscle Satellite Cultured Cells	--
45	chr6:150463200-150463600	Flanking Active TSS	Brain Anterior Caudate	brain
46	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
47	chr6:150463200-150463600	Flanking Bivalent TSS/Enh	Brain Substantia Nigra	brain
48	chr6:150463200-150463600	Flanking Active TSS	Fetal Brain Male	brain
49	chr6:150463200-150463600	Flanking Active TSS	Fetal Heart	heart
50	chr6:150463200-150463600	Flanking Active TSS	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links